YTEN - Yield10 Bioscience Inc
Previous close
1.28
0 0%
Share volume: 115,032
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.28
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
| Report Date | 2022-05-11 | 2022-08-10 | 2022-11-14 | 2023-03-14 | 2023-05-12 | |
| Total revenue | 149.000 K | 103.000 K | 111.000 K | 87.000 K | 60.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 149.000 K | 103.000 K | 111.000 K | 87.000 K | 60.000 K | |
| -30.87% | 7.77% | -21.62% | -31.03% | |||
| Operating expenses | 3.470 M | 3.539 M | 3.601 M | 3.291 M | 3.860 M | |
| Selling general and admin | 1.707 M | 1.523 M | 1.518 M | 1.403 M | 1.698 M | |
| Research and development | 1.763 M | 2.016 M | 2.083 M | 1.888 M | 2.162 M | |
| Total expenses | 3.470 M | 3.539 M | 3.601 M | 3.291 M | 3.860 M | |
| 1.99% | 1.75% | -8.61% | 17.29% | |||
| Operating income | -3.321 M | -3.436 M | -3.490 M | -3.204 M | -3.800 M | |
| Ebit | -3.321 M | -3.436 M | -3.490 M | -3.204 M | -3.800 M | |
| Pretax income | -3.322 M | -3.434 M | -3.480 M | -3.174 M | -3.782 M | |
| 3.37% | 1.34% | -8.79% | 19.16% | |||
| Income tax | 9.000 K | 9.000 K | 9.000 K | 129.000 K | 0.000 | |
| Net income basic | -3.331 M | -3.443 M | -3.489 M | -3.303 M | -3.782 M | |
| -3.36% | -1.34% | 5.33% | -14.50% | |||
| Net income | -3.331 M | -3.443 M | -3.489 M | -3.303 M | -3.782 M | |
| -3.36% | -1.34% | 5.33% | -14.50% |